# US 2026/0108298 A1 · Ablation and occlusive system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0108298 A1
- Document ID: US20260108298A1
- Status: Published application
- Kind: A1
- Application number: 19/414,795
- Filed: 2025-12-10
- Published: 2026-04-23
- Earliest claimed: 2018-07-09
- Assignees: Boston Scientific Scimed, Inc.; Mayo Foundation for Medical Education and Research
- Applicants: Boston Scientific Scimed, Inc.; Mayo Foundation for Medical Education and Research
- Inventors: SARAH MELISSA GRUBA; JAMES P. ROHL; JAMES A. KLOS; JOHN M. EDGELL; DOUGLAS DEAN PAGORIA; SAMUEL J. ASIRVATHAM
- Web page: https://patentgrep.com/patent/US20260108298A1

## CPC

- A61B 17/12122: {within the heart (for closing a cardiac septal defect A61B17/0057)}
- A61B 18/1492: {having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence)}
- A61B 17/12136: {Balloons}
- A61B 17/12172: {having a pre-set deployed three-dimensional shape (methods of manufacturing A61B2017/00526)}
- A61B 18/082: {Probes or electrodes therefor}
- A61B 18/1206: {Generators therefor}
- A61B 5/0538: invasively, e.g. using a catheter
- A61B 5/6853: {with a balloon}
- A61B 17/12045: {double occlusion, e.g. during anastomosis}
- A61B 2017/00053: {Mapping}
- A61B 2017/00243: {cardiac}
- A61B 2017/00477: {Coupling (A61B2017/0046 takes precedence)}
- A61B 2017/00876: {magnetic}
- A61B 2018/00059: {Material properties}
- A61B 2018/0016: {Energy applicators arranged in a two- or three dimensional array}
- A61B 2018/0022: {Balloons}
- A61B 2018/00238: {porous}
- A61B 2018/00261: {arranged in a line}
- A61B 2018/00351: {Heart}
- A61B 2018/00375: {Ostium, e.g. ostium of pulmonary vein or artery}
- A61B 2018/00577: {Ablation}
- A61B 2018/00589: {Coagulation}
- A61B 2018/00613: {Irreversible electroporation}
- A61B 2018/00791: {Temperature}
- A61B 2018/00839: {Bioelectrical parameters, e.g. ECG, EEG}
- A61B 2018/1253: {monopolar}
- A61B 2018/126: {bipolar}
- A61B 2018/1472: {for use with liquid electrolyte, e.g. virtual electrodes}
- A61B 2090/374: {NMR or MRI}
- A61B 2090/376: {using X-rays, e.g. fluoroscopy}
- A61B 2090/3966: {Radiopaque markers visible in an X-ray image}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

An example medical system for ablating and occluding the left atrial appendage is disclosed. The example system includes a catheter sized and shaped for vascular access and including an elongate body extending between a proximal end and a distal end. A first expandable member may be positioned near the distal end of the elongate body and have a first region configured to permeate a liquid therethrough. A first set of one or more electrodes may be arranged within the first expandable member and may be configured to deliver energy to the tissue region. An occlusive implant may be releasably secured to the distal end of the elongate body.

## Claims

### Claim 1

A method for applying ablation therapy to a tissue region within a patient's heart and delivering an occlusive implant, the method comprising:
navigating a catheter within the patient's heart, the catheter including an elongate body extending between a proximal end and a distal end;
positioning and expanding a first expandable member having one or more electrodes and the occlusive implant at the tissue region, the first expandable member and the occlusive implant being positioned near the distal end of the elongate body;
delivering a direct current energy to the tissue region through the one or more electrodes; and
releasing the occlusive implant adjacent to the tissue region.

### Claim 2 (depends on 1)

The method of claim 1, wherein the direct current energy is delivered at a voltage in a range of about 1000 volts to about 5000 volts.

### Claim 3 (depends on 1)

The method of claim 1, wherein the direct current energy is delivered at a rate of about 1 to about 100 pulses per heartbeat.

### Claim 4 (depends on 1)

The method of claim 1, wherein the first expandable member includes a first region configured to permeate a liquid therethrough, the first region positioned over the one or more electrodes.

### Claim 5 (depends on 1)

The method of claim 1, further comprising mapping an electrical activity of the tissue region after delivering the direct current energy.

### Claim 6

A method for applying ablation therapy to a tissue region within a patient's heart and delivering an occlusive implant, the method comprising:
navigating a catheter within the patient's heart, the catheter including an elongate body extending between a proximal end and a distal end;
positioning and expanding a first expandable member having one or more electrodes and a second expandable member having one or more electrodes at the tissue region, the first expandable member and the second expandable member being positioned near the distal end of the elongate body;
delivering a direct current energy to the tissue region through the one or more electrodes of the first expandable member; and
after delivering the direct current energy:
removing the catheter from the patient's heart;
releasably coupling the occlusive implant to the distal end of the elongate body;
navigating the catheter to the tissue region; and
releasing the occlusive implant adjacent to the tissue region.

### Claim 7 (depends on 6)

The method of claim 6, wherein the direct current energy is delivered at a voltage in a range of about 1000 volts to about 5000 volts.

### Claim 8 (depends on 6)

The method of claim 6, wherein the direct current energy is delivered at a rate of about 1 to about 100 pulses per heartbeat.

### Claim 9 (depends on 6)

The method of claim 6, wherein the first expandable member includes a first region configured to permeate a liquid therethrough, the first region positioned over the one or more electrodes.

### Claim 10 (depends on 6)

The method of claim 6, wherein the second expandable member includes a first region configured to permeate a liquid therethrough, the first region positioned over the one or more electrodes.

### Claim 11 (depends on 6)

The method of claim 6, further comprising mapping an electrical activity of the tissue region after delivering the direct current energy and before removing the catheter from the patient's heart.

### Claim 12

A method for applying ablation therapy to a tissue region within a patient's heart and delivering an occlusive implant, the method comprising:
navigating a catheter within the patient's heart, the catheter including an elongate body extending between a proximal end and a distal end;
positioning and expanding a first expandable member at the tissue region within the heart, the first expandable member having a permeable region configured to permeate an electrically conductive liquid therethrough and one or more electrodes arranged within the first expandable member, the first expandable member and the occlusive implant being positioned near the distal end of the elongate body;
delivering direct current energy through the electrically conductive liquid to the tissue region through the one or more electrodes; and
delivering the occlusive implant within the heart after delivering the direct current energy.

### Claim 13 (depends on 12)

The method of claim 12, wherein the tissue region within the heart includes a left atrial appendage, and delivering the occlusive implant within the heart includes occluding the left atrial appendage.

### Claim 14 (depends on 13)

The method of claim 13, wherein the occlusive implant includes a self-expanding frame structure with a mesh filter membrane configured to prevent thrombi from exiting the left atrial appendage, and wherein the self-expanding frame structure is configured to promote endothelial growth after deployment.

### Claim 15 (depends on 13)

The method of claim 13, wherein the first expandable member and the occlusive implant are positioned within the left atrial appendage such that the first expandable member contacts tissue at or near an ostium of the left atrial appendage during delivery of the direct current energy.

### Claim 16 (depends on 12)

The method of claim 12, wherein the direct current energy is delivered at a voltage in a range of about 1000 volts to about 5000 volts.

### Claim 17 (depends on 12)

The method of claim 12, wherein the direct current energy is delivered at a rate of about 1 to about 100 pulses per heartbeat.

### Claim 18 (depends on 12)

The method of claim 12, wherein the first expandable member includes the permeable region positioned over the one or more electrodes to transfer the direct current energy from the one or more electrodes through the electrically conductive liquid to the tissue region.

### Claim 19 (depends on 12)

The method of claim 12, further comprising positioning and expanding a second expandable member between the first expandable member and the occlusive implant, the second expandable member having a permeable region configured to permeate a liquid therethrough and one or more electrodes arranged within the second expandable member configured to form a ground for the direct current energy delivered by the one or more electrodes of the first expandable member.

### Claim 20 (depends on 12)

The method of claim 12, wherein delivering direct current energy includes delivering pulses during a refractory period of a heartbeat, and wherein in a range of about 10 to about 1000 pulses are delivered over a total electroporation period.
